Dhamrait, Gursimran K.
Panchal, Kunjal
Fleury, Naomi J.
Abel, Tamara N.
Ancliffe, Mathew K.
Crew, Rachael C.
Croft, Kevin
Fernandez, Bernadette O.
Minnion, Magdalena
Hart, Prue H.
Lucas, Robyn M.
Mark, Peter J.
Feelisch, Martin
Weller, Richard B.
Matthews, Vance
Gorman, Shelley http://orcid.org/0000-0002-7111-6735
Funding for this research was provided by:
Diabetes Research Foundation Western Australia
Telethon Kids Institute
Rebecca L Cooper Medical Research Foundation
Article History
Received: 21 March 2019
Accepted: 29 August 2019
First Online: 11 November 2019
Duality of interest
: MF and RBW are members of the Scientific Advisory Board of AOBiome LLC, a company commercialising ammonia-oxidising bacteria for use in inflammatory skin disease. RBW is also a director of, and MF a scientific advisor for, RelaxSol Ltd, a company developing novel sunscreen and skincare products. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.
Free to read: This content has been made available to all.